Linked Life Data

21154400

Source:http://linkedlifedata.com/resource/pubmed/id/21154400

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
12
pubmed:dateCreated
2010-12-14
pubmed:abstractText
Controlled clinical trials investigating the efficacy of aminosalicylates for the treatment of mildly to moderately active Crohn's disease have yielded conflicting results. A systematic review was conducted to critically examine current available data on the efficacy of sulfasalazine and mesalamine for inducing remission or clinical response in patients with mildly to moderately active Crohn's disease.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:issn
1469-493X
pubmed:author
pubmed:issnType
Electronic
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
CD008870
pubmed:dateRevised
2011-3-9
pubmed:meshHeading
pubmed:year
2010
pubmed:articleTitle
Aminosalicylates for induction of remission or response in Crohn's disease.
pubmed:affiliation
Department of Gastroenterology and Hepatology, Tan Tock Seng Hospital, 11 Jalan Tan Tock Seng, Singapore, Singapore, S 308433.
pubmed:publicationType
Journal Article, Review, Meta-Analysis